Navigation Links
STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
Date:1/14/2010

Area and Severity Index (PASI 75) at week 12, the primary endpoint, compared with 57 percent of patients receiving subcutaneous injections of 50 mg etanercept twice per week for 12 weeks (P = 0.01 for STELARA 45 mg; P < 0.001 for STELARA 90 mg, each compared with etanercept).  Onset of clinical response appeared more rapidly among STELARA-treated patients, with higher numbers of patients achieving PASI 75 by week 8 compared with patients receiving etanercept.  

Investigators also reported that a greater proportion of patients receiving STELARA achieved a marked improvement in psoriasis as assessed by PASI 90 response, or nearly complete clearance of psoriasis.  At week 12, 36 percent of patients receiving STELARA 45 mg and 45 percent of patients receiving STELARA 90 mg achieved PASI 90 compared with 23 percent of patients receiving etanercept (P < 0.001 for each comparison versus etanercept).  Moreover, a greater proportion of patients in both the STELARA 45 mg and 90 mg treatment groups achieved a Physician Global Assessment (PGA) score of "cleared" or "minimal" (65 percent and 71 percent, respectively) compared with patients in the etanercept treatment group (49 percent) (P < 0.001 for each comparison versus etanercept).

Patients who had an inadequate response to etanercept, as measured by PGA score (classified as moderate, marked or severe psoriasis at week 12), received one injection of STELARA 90 mg at weeks 16 and 20.  At week 28, investigators reported that 49 and 23 percent of patients who failed to respond to etanercept and who crossed over to STELARA achieved PASI 75 and PASI 90, respectively.

In addition, patients classified as responders (having a PGA score of cleared, minimal or mild) at week 12 discontinued therapy until recurrence of psoriasis (PGA of moderate or greater).  In these patients, the median length of time to disease recurrence was l
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... India , September 3, 2015 ... Metallic compounds, Organosulfurs, Organic acids, Phenolics, and Others) and ... & beverage, Paints & coatings, and Others) - Global ... and segments the Biocides Market with an analysis and ... as value. Browse   88 tables ...
(Date:9/2/2015)... Balloon angioplasty is a minimally invasive ... report is on global angioplasty balloons studies the ... report comprises an elaborate executive summary, which includes ... various segments and sub-segments included in the study. ... data analysis of the global angioplasty balloons market ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... artificial implants used to replace, augment, or repair ... a wide range of applications including cosmetic, spinal, ... are made of different materials such as polymers, ... the global implantable medical devices market to grow ...
Breaking Medicine Technology:Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Implantable Medical Devices Market 2015-2019 2
... Corporation (NYSE: GPX ), announced today that ... with and into its wholly-owned subsidiary, General ... Physics, which is the sole operating subsidiary of GP ... be renamed GP Strategies Corporation when the merger becomes ...
... 15, 2011  MedAssurant, Inc., a leading provider ... Healthcare Partners, IPA (HCPIPA), one of the ... the Northeast, has selected MedAssurant,s Prospective Advantage® ... proactively identify gaps in care and quality ...
Cached Medicine Technology:GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 2GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 3Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 2Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 3
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an ... Google Play , and Amazon and will be released on DVD early ... Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, lead from ...
(Date:9/3/2015)... ... 2015 , ... At Renew Man™, we have seen an increasing number of ... where the primary care physician dictates and the patient obeys. Instead, our clients are ... health issues and empowered to choose their own treatment options. , Recognizing that many ...
(Date:9/3/2015)... , ... September 03, 2015 , ... James Earl Jones ... workplace wellness. In this episode, James Earl Jones will introduce a segment that discusses ... unhealthy workplace and how workplace wellness can be fostered in any working environment. , ...
(Date:9/3/2015)... ... September 03, 2015 , ... Fashion designer Kim (29 years old, ... most recent episode of the hit ABC series “Extreme Weight Loss” Season 5 ... her industry. She provided herself with the motivation to transform when she designed a ...
(Date:9/2/2015)... ... September 03, 2015 , ... Sara ... Bloomberg School of Public Health and an internationally recognized scholar on obesity prevention ... 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of Garrison Forest School, ...
Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... international team of scientists led by researchers at the University ... pluripotent stem cells (iPSCs) derived from patients with amyotrophic lateral ... levels of a specific protein may play a central role ... The work, published in the June 2011 online issue ...
... By Alan Mozes HealthDay Reporter , TUESDAY, June ... research suggests that repeated bouts of unemployment don,t affect everyone ... people who are consistently successful in finding new work after ... so-called "serial joblessness" than are those who lose a job ...
... strong evidence indicates that policies beyond the health sector ... U.S. government should adopt a structured approach to considering ... says a new report by the Institute of Medicine. ... and revise public health laws so that they adequately ...
... Reporter , MONDAY, June 20 (HealthDay News) -- Evaluating ... lower blood pressure requires multiple readings, new research suggests. ... condition known as "white coat" hypertension, so readings should ... study,s lead author, Dr. Benjamin Powers, assistant professor of ...
... laid, their natural resistance to pathogens begins to wear down, ... rearm those defenses. Kevin Keener, an associate professor of ... is designed to inhibit the growth of bacteria such as ... an egg with carbon dioxide and alter pH levels, which ...
... cancer who don,t live near a major academic medical center ... The University of Alabama at Birmingham Comprehensive Cancer Center ... bring leading-edge care to these communities, giving patients an opportunity ... access to leading cancer research. The UAB ...
Cached Medicine News:Health News:Stem cell model offers clues to cause of inherited ALS 2Health News:Unemployment May Hit Some Harder Than Others 2Health News:Unemployment May Hit Some Harder Than Others 3Health News:Unemployment May Hit Some Harder Than Others 4Health News:Government should consider public health implications of all major legislation 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 3Health News:Cooling system may build eggs' natural defenses against salmonella 2Health News:UAB Comprehensive Cancer Center launches Cancer Care Network 2
... is an economically priced 4-channel data ... research use in the fields of ... biology, zoology, biochemistry and biomedical engineering. ... signal conditioners and transducers. Two Pod ...
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
Tumbling E/20' distance chart 22-1/2" X 11" 20/200 to 20/10....
... charts contain 5 pages of various contrast levels ... size is 9.5M. Contrast levels are 25%, 10%, ... be used at several different distances. These two ... offers a different set of symbols to ...
Medicine Products: